TLCR Reading Tools
How to cite item
Efficacy and safety of anlotinib plus EGFR tyrosine kinase inhibitors in slow- or locally progressing non-small cell lung cancer after adjuvant therapy
Citation Format
ABNT
APA
BibTeX
CBE
EndNote - EndNote format (Macintosh & Windows)
MLA
ProCite - RIS format (Macintosh & Windows)
RefWorks
Reference Manager - RIS format (Windows only)
Turabian
@article{{TLCR}{99197}, author = {Ye, J., Liu, J., Ma, Y., Lv, W., Xu, W., Aoki, M., Yang, Y., Xia, P., Wang, L., Zhu, L., Hu, J.}, title = {Efficacy and safety of anlotinib plus EGFR tyrosine kinase inhibitors in slow- or locally progressing non-small cell lung cancer after adjuvant therapy}, journal = {Translational Lung Cancer Research}, volume = {0}, number = {0}, year = {2025}, url = {https://tlcr.amegroups.org/article/view/99197} }